Key result
Higher parathyroid hormone is linked to increased arterial stiffness in type 1 diabetes.
Cohort (n=347)
No
In patients with type 1 diabetes, higher parathyroid hormone levels are associated with increased arterial stiffness, suggesting a link between vascular calcification and bone metabolism.
Answers are grounded in this paper and cite their sources.
Does not support practice change in type 1 diabetes; hypothesis-generating for PTH-vascular links.
Vascular calcification is a common consequence of aging, hypercholesterolemia, chronic renal insufficiency, and diabetes (1). Stiffening of the large arteries is a result of vascular calcification. Carotid–femoral pulse wave velocity (cfPWV) is considered the gold standard measure of arterial stiffness (2) and has been shown to be a strong predictor of mortality and cardiovascular outcome. We evaluated the association between arterial stiffness (evaluated by cfPWV) and bone mass density (evaluated with dual-energy X-ray absorptiometry at the femoral neck), as well as a comprehensive panel of bone markers, in a well-characterized cohort of 347 persons with type 1 diabetes. We hypothesized that vascular calcification is linked to decalcification of the bones. The participants were recruited from the outpatient clinic at Steno Diabetes Center, Gentofte, Denmark. Written informed patient consent and ethical approval of the study were obtained. A total of 164 (47%) participants were women, mean ± SD age was 55.8 ± 9.6 years and cfPWV was 11.0 ± 3.4 m/s, and median …
No takes yet. Share an insight, caveat, or question.
Zobel et al. (2017) conducted a cohort in Type 1 diabetes (n=347). Parathyroid hormone level was evaluated on Arterial stiffness (evaluated by carotid-femoral pulse wave velocity). Higher parathyroid hormone level is associated with increased arterial stiffness in patients with type 1 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: